BioXcel Corporation, a global leader in cloud-based big data platforms and developer of transformative patient treatments, today announced the launch of the latest version of its cloud-based pharma big data analytics platform - PharmGPS™ 2.0. This proprietary platform integrates BioXcel's ApolloTRIM discovery engine with its PharmGPSTM Decision Genius platform, providing recursive-mapping capabilities for drug discovery and predictive analytics. The inherent nature of the platform is highly disruptive. It is able to rapidly generate therapeutic area galactic maps for any disease and apply network-based pharmacology to uncover novel pharmaceutical product opportunities. The platform has in-built predictive and cognitive capabilities capable of addressing the complex decision making needs of the pharmaceutical and biotechnology industry.
The company's President and Chief Scientific Officer, Krishnan Nandabalan and VP, Oncology R&D, Luca Rastelli will be showcasing the power of the PharmGPS™ Platform in their joint presentation titled 'Big Data to Clinical Leads' at Phacilitate's Big Data in Clinical Development conference in Washington D.C on October 7th- 8th.
PharmGPS™ 2.0 enables the comprehensive assessment of both structured and unstructured data to generate actionable results across all major therapeutic areas. By providing "pan-therapeutic area" access and analyses, PharmGPS™ 2.0 allows users to accurately map the biological connections and relationships between diseases, drugs and MOAs to identify drug candidates. In addition, the platform offers a responsive, intuitive and attractive interface with a variety of tools, customizable features and high definition graphics. These attributes enable multiple scenario analyses related to disease prioritization, clinical and preclinical performance benchmarking, projected market performance and portfolio optimization. The platform has resulted in the development and expansion of the Company's portfolio across multiple therapeutic areas.
This article has been extracted from http://www.globenewswire.com, please click on this link to read the article in full http://www.globenewswire.com/news-release/2015/10/07/774196/10151932/en/BioXcel-Unveils-Next-Generation-Big-Data-Analytics-Platform-PharmGPS-TM-2-0.html
Montash is a multi-award winning global technology recruitment business. Specialising in permanent and contract positions across mid-senior appointments across a wide range of industry sectors and IT functions, including:
ERP Recruitment, BI & Data Recruitment, Information Security Recruitment, Enterprise Architecture & Strategy Recruitment , Energy Technology Recruitment, Demand IT and Business Engagement Recruitment, Digital and E-commerce Recruitment, Leadership Talent, Infrastructure and Service Delivery Recruitment, Project and Programme Delivery Recruitment.
Montash is headquartered in Old Street, London, in the heart of the technology hub. Montash has completed assignments in over 30 countries and has appointed technical professionals from board level to senior and mid-management in permanent and contract roles.